Literature DB >> 23940002

Analysis of microRNAs expressions in chondrosarcoma.

Teruhito Yoshitaka1, Akira Kawai, Shigeru Miyaki, Kunihiko Numoto, Kazutaka Kikuta, Toshifumi Ozaki, Martin Lotz, Hiroshi Asahara.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs capable of inhibiting gene expression post-transcriptionally and expression profiling can provide therapeutic targets and tools for cancer diagnosis. Chondrosarcoma is a mesenchymal tumor with unknown cause and differentiation status. Here, we profiled miRNA expression of chondrosarcoma, namely clinical samples from human conventional chondrosarcoma tissue, established chondrosarcoma cell lines, and primary non-tumorous adult articular chondrocytes, by miRNA array and quantitative real-time PCR. A wide variety of miRNAs were differently downregulated in chondrosarcoma compared to non-tumorous articular chondrocytes; 27 miRNAs: miR-10b, 23b, 24-1*, 27b, 100, 134, 136, 136*, 138, 181d, 186, 193b, 221*, 222, 335, 337-5p, 376a, 376a*, 376b, 376c, 377, 454, 495, 497, 505, 574-3p, and 660, were significantly downregulated in chondrosarcoma and only 2: miR-96 and 183, were upregulated. We further validated the expression levels of miRNAs by quantitative real-time PCR for miR-181a, let-7a, 100, 222, 136, 376a, and 335 in extended number of chondrosarcoma clinical samples. Among them, all except miR-181a were found to be significantly downregulated in chondrosarcoma derived samples. The findings provide potential diagnostic value and new molecular understanding of chondrosarcoma.
© 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  cartilage; chondrosarcoma; malignancy; microRNA; sarcoma

Mesh:

Substances:

Year:  2013        PMID: 23940002      PMCID: PMC3835201          DOI: 10.1002/jor.22457

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  24 in total

1.  Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components.

Authors:  F Barry; R E Boynton; B Liu; J M Murphy
Journal:  Exp Cell Res       Date:  2001-08-15       Impact factor: 3.905

2.  A web-based tool for principal component and significance analysis of microarray data.

Authors:  Alexei A Sharov; Dawood B Dudekula; Minoru S H Ko
Journal:  Bioinformatics       Date:  2005-02-25       Impact factor: 6.937

3.  MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.

Authors:  Carl Morrison; Michael Radmacher; Nehad Mohammed; David Suster; Herbert Auer; Susie Jones; Judy Riggenbach; Nicole Kelbick; Gary Bos; Joel Mayerson
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation.

Authors:  Nobuhiro Kamiya; Hideto Watanabe; Hiroko Habuchi; Hidekazu Takagi; Tamayuki Shinomura; Katsuji Shimizu; Koji Kimata
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

5.  Chondrocyte apoptosis induced by nitric oxide.

Authors:  F J Blanco; R L Ochs; H Schwarz; M Lotz
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

6.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

7.  miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma.

Authors:  Yongxia Zheng; Lei Yin; Huan Chen; Shengsheng Yang; Chuanyong Pan; Shan Lu; Mingyong Miao; Binghua Jiao
Journal:  FEBS Lett       Date:  2012-06-07       Impact factor: 4.124

8.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 9.  The staging and surgery of musculoskeletal neoplasms.

Authors:  R E Wolf; W F Enneking
Journal:  Orthop Clin North Am       Date:  1996-07       Impact factor: 2.472

10.  Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.

Authors:  J T Hecht; D Hogue; L C Strong; M F Hansen; S H Blanton; M Wagner
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

View more
  26 in total

1.  miR-148b-3p, miR-337-5p and miR-423-5p expression in alveolar ridge atrophy and their roles in the proliferation and apoptosis of OMMSCs.

Authors:  Sefei Yang; Jun Guo; Lei Zhou; Helin Xing; Xianli Wang; Chaofang Dong
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

Review 2.  Epigenetics of osteoarticular diseases: recent developments.

Authors:  S B Roberts; E Wootton; L De Ferrari; O M Albagha; D M Salter
Journal:  Rheumatol Int       Date:  2015-03-27       Impact factor: 2.631

Review 3.  MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma.

Authors:  Feifei Pu; Fengxia Chen; Zengwu Shao
Journal:  Tumour Biol       Date:  2016-10-11

4.  CORR Insights®: MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.

Authors:  Rong-Sen Yang
Journal:  Clin Orthop Relat Res       Date:  2014-09-30       Impact factor: 4.176

Review 5.  Review of microRNA in osteosarcoma and chondrosarcoma.

Authors:  Le Chang; Swati Shrestha; Greg LaChaud; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

6.  Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells.

Authors:  Aslı Tetik Vardarlı; Zekeriya Düzgün; Ceren Erdem; Burçin Tezcanli Kaymaz; Zuhal Eroglu; Vildan Bozok Çetintas
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

7.  MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.

Authors:  Xiaojuan Sun; Lei Wei; Qian Chen; Richard M Terek
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

8.  MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells.

Authors:  Jun Lin; Li Wang; Jie Gao; Shiguang Zhu
Journal:  Exp Ther Med       Date:  2017-07-24       Impact factor: 2.447

Review 9.  MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics.

Authors:  Jyotika Varshney; Subbaya Subramanian
Journal:  Front Mol Biosci       Date:  2015-06-17

10.  Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids.

Authors:  Clément Veys; Abderrahim Benmoussa; Romain Contentin; Amandine Duchemin; Emilie Brotin; Jérôme E Lafont; Yannick Saintigny; Laurent Poulain; Christophe Denoyelle; Magali Demoor; Florence Legendre; Philippe Galéra
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.